|
Blue Cross designates record number of physician practices as patient-centered medical homes
For the eighth consecutive year, Blue Cross Blue Shield of Michigan and its physician partners lead the nation in advancing the patient-centered medical home model of care. A total of 1,638 practices — with 4,534 physicians — have earned designation as patient-centered medical homes. Read more.
A message from Dr. S.George Kipa
Tribute to cancer researcher highlights great work in Michigan
Earlier this year, I had the pleasure of attending a tribute to Karmanos Cancer Institute researcher Gloria Heppner, who was being recognized for her contributions to cancer research. In particular, she was cited* for writing one of the most influential scientific articles in the history of the journal Cancer Research. Her article on tumor heterogeneity was described as “more often highlighted by editors, American Association for Cancer Research fellows and cancer researchers than any other [article].” Read more.
The mind-body connection
Integrating behavioral health with primary care: a key focus of our Physician Group Incentive Program
At Blue Cross Blue Shield of Michigan, we recognize the important role that behavioral health practitioners can play in improving patient care. In addition to treating patients with psychiatric disorders, they can help patients cope with chronic medical problems, comply with medication regimens and adjust to life changes, stress, anxiety and pain. Read more.
A message from Laurie Wesolowicz
Director, Clinical Pharmacy Services, Blue Cross Blue Shield of Michigan
5 things doctors need to know about specialty drugs and health insurance affordability
U.S. health care costs are rising faster than inflation. At Blue Cross, we spend a lot of time thinking about how we can help reverse this trend — and create additional value for our customers and members. Read more.
Focus on pharmacy
Tablet splitting: A risky practice
Tablet splitting may seem like a great way for patients to save money on their prescriptions but, according to the Food and Drug Administration, tablet splitting is a risky practice that can adversely affect patient safety. In certain circumstances, tablet splitting may be clinically indicated, such as when patients have difficulty swallowing or if an appropriate dose for a patient is not commercially available. Read more.
In Brief
Prior authorization program expands
We want to make sure you’re aware of a recent expansion to our prior authorization program. Read more. |
